XXXIII Congreso Nacional de la Sociedad Española de Trombosis y Hemostasia

Ponencias 105 patients with severe Bernard-Soulier Syndrome. Thromb Haemost 2006;95:190-1. 21. Kim C. Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application. Blood Res 2014;49:7-14. 22. López-Onieva L, Montes R, Lamolda M, Romero T, Ayllon VV, Lozano ML, et al. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene. Stem Cell Res 2016 DOI: 10.1016/j. scr.2016.04.013. 23. López-Onieva L, Machuca C, Lamolda M, Montes R, Lozano ML, Vicente V, et al. Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene. Stem Cell Res 2016;17:603-6. 24. López-Onieva L, Lamolda M, Montes R, Lozano ML, Vicente V, Rivera J, et al. Induced pluripotent stem cells derived from Bernard-Soulier Syndrome patient´s peripheral blood cells with a p.Phe55Ser mutation in the GPIX gene. Stem Cell Res 2017;20:10-3. 25. Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T, et al. Generation of functional platelets from human embryon- ic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 2008;111:5298-306. 26. Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 2010;207:2817-30. 27. Lu S-J, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, et al. Plate- lets generated from human embryonic stem cells are function- al in vitro and in the microcirculation of living mice. Cell Res 2011;21:530-45. 28. Toscano MG, Navarro-Montero O, Ayllon V, Ramos-Mejia V, Gue- rrero-Carreno X, Bueno C, et al. SCL/TAL1-mediated transcrip- tional network enhances megakaryocytic specification of human embryonic stem cells. Mol Ther 2015;23:158-70.